Abstract
Mood disorders such as major depression and bipolar disorder are common, severe, chronic and often lifethreatening illnesses. Suicide is estimated to be the cause of death in up to approximately 10-15% of individuals with mood disorders. Alterations in the signal transduction through G protein-coupled receptor (GPCR) pathways have been reported in the etiopathology of mood disorders and the suicidal behavior. In this regard, the implication of certain GPCR subtypes such as α2A-adrenoceptor has been repeatedly described using different approaches. However, several discrepancies have been recently reported in density and functional status of the heterotrimeric G proteins both in major depression and bipolar disorder. A compilation of the most relevant research topics about the implication of heterotrimeric G proteins in the etiology of mood disorders (i.e., animal models of mood disorders, studies in peripheral tissue of depressive patients, and studies in postmortem human brain of suicide victims with mood disorders) will provide a broad perspective of this potential therapeutic target field. Proposed causes of the discrepancies reported at the level of G proteins in postmortem human brain of suicide victims will be discussed.
Keywords: Mood disorders, major depression, bipolar disorder, suicide, heterotrimeric G proteins, G protein-coupled receptors (GPCR), α2-adrenoceptors
Current Neuropharmacology
Title: Heterotrimeric G Proteins: Insights into the Neurobiology of Mood Disorders
Volume: 4 Issue: 2
Author(s): Javier Gonzalez-Maeso and J. J. Meana
Affiliation:
Keywords: Mood disorders, major depression, bipolar disorder, suicide, heterotrimeric G proteins, G protein-coupled receptors (GPCR), α2-adrenoceptors
Abstract: Mood disorders such as major depression and bipolar disorder are common, severe, chronic and often lifethreatening illnesses. Suicide is estimated to be the cause of death in up to approximately 10-15% of individuals with mood disorders. Alterations in the signal transduction through G protein-coupled receptor (GPCR) pathways have been reported in the etiopathology of mood disorders and the suicidal behavior. In this regard, the implication of certain GPCR subtypes such as α2A-adrenoceptor has been repeatedly described using different approaches. However, several discrepancies have been recently reported in density and functional status of the heterotrimeric G proteins both in major depression and bipolar disorder. A compilation of the most relevant research topics about the implication of heterotrimeric G proteins in the etiology of mood disorders (i.e., animal models of mood disorders, studies in peripheral tissue of depressive patients, and studies in postmortem human brain of suicide victims with mood disorders) will provide a broad perspective of this potential therapeutic target field. Proposed causes of the discrepancies reported at the level of G proteins in postmortem human brain of suicide victims will be discussed.
Export Options
About this article
Cite this article as:
Gonzalez-Maeso Javier and Meana J. J., Heterotrimeric G Proteins: Insights into the Neurobiology of Mood Disorders, Current Neuropharmacology 2006; 4 (2) . https://dx.doi.org/10.2174/157015906776359586
DOI https://dx.doi.org/10.2174/157015906776359586 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Lobar Atrophy in Frontotemporal Dementia: Diagnostic and Prognostic Implications
Current Alzheimer Research New Pharmacotherapy Targeting Cognitive Dysfunction of Schizophrenia via Modulation of GABA Neuronal Function
Current Neuropharmacology Polyunsaturated Fatty Acids in Pregnancy and Metabolic Syndrome: A Review
Current Pharmaceutical Biotechnology Antidiabetic Effect of Polyphenolic Extracts from Selected Edible Plants as α-Amylase, α -Glucosidase and PTP1B Inhibitors, and β Pancreatic Cells Cytoprotective Agents - A Comparative Study
Current Topics in Medicinal Chemistry Possible Involvement of Advanced Glycation End-Products (AGEs) in the Pathogenesis of Alzheimers Disease
Current Pharmaceutical Design BACE1 Levels by APOE Genotype in Non-Demented and Alzheimer’s Post-Mortem Brains
Current Alzheimer Research The Valsalva Maneuver and Alzheimers Disease: Is there a link?
Current Alzheimer Research Structural and Functional Relationships Between GSK3α and GSK3β Proteins
Current Biotechnology A Sample Selection Strategy to Boost the Statistical Power of Signature Detection in Cancer Expression Profile Studies
Anti-Cancer Agents in Medicinal Chemistry Non-Selective Cation Channel Blockers: Potential Use in Nervous System Basic Research and Therapeutics
Mini-Reviews in Medicinal Chemistry Current Nanoparticle Approaches in Nose to Brain Drug Delivery and Anticancer Therapy - A Review
Current Pharmaceutical Design Current Knowledge on the Antagonists and Inverse Agonists of Cannabinoid Receptors
Current Medicinal Chemistry Capillary Electrophoresis Interfaced with a Mass Spectrometer (CE-MS): Technical Considerations and Applicability for Biomarker Studies in Animals
Current Protein & Peptide Science Phenothiazine: The Parent Molecule
Current Drug Targets Risk Communication of Vaccines: Challenges in the Post-Trust Environment
Current Drug Safety Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets Health Economic Modelling in Stratified Medicine - Example Depression
Current Pharmacogenomics and Personalized Medicine Strategies for the Synthesis of Hydroxamic Acids
Current Organic Synthesis Family-Based Therapy for Adolescent Anorexia: The Nuts and Bolts of Empowering Families to Renourish Their Children
Adolescent Psychiatry Pre-Clinical Evidence that Corticotropin-Releasing Factor (CRF) Receptor Antagonists are Promising Targets for Pharmacological Treatment of Alcoholism
CNS & Neurological Disorders - Drug Targets